Box Office: ‘Five Nights at Freddy’s 2’ Opening to Historic $57M, Scares Off Post-Thanksgiving Slump

Five Nights at Freddy’s 2 opened to an estimated $56.6 million from 3,412 theaters, posting the largest post-Thanksgiving frame opening ever (unadjusted) and the biggest December horror debut, despite weak critic scores (13% on Rotten Tomatoes) and a B CinemaScore. Disney’s Zootopia 2 is projected at $45 million (domestic total >$222M) and Universal’s Wicked: For Good is estimated at $15.6 million in its third weekend (domestic $296M), while Jujutsu Kaisen: Execution is estimated at $10M and two Lionsgate reissues each near $4M. The results underscore strong franchise and audience-driven box-office resilience—supportive for studio revenue and sequel valuations—and highlight potential upside for Universal/Blumhouse amid their recent merger activity with Atomic Monster.

Analysis

Market structure: A $56.6M domestic opener for Five Nights at Freddy’s 2 signals clear winners—Universal/Blumhouse (UVV exposure), theatrical exhibitors, and licensors of IP-driven horror—while non-IP mid‑budget releases and streaming‑first titles face further crowding out. This front‑loaded consumer demand (B CinemaScore vs 13% critics) increases studios' short‑term pricing power for event releases and strengthens theatrical revenue leverage vs subscription models; expect modest tightening in studio credit spreads and higher IV in media equities around release windows.

Risk assessment: Tail risks include franchise fatigue, international underperformance (movies can lose >30% of expected global receipts), renewed talent strikes affecting production pipelines, or backend litigation over profit participation; any of these could swing valuations by >15% for exposed names. Immediate (days) risk is headline-driven IV swings; short term (weeks/months) is holiday box‑office carry; long term (quarters/years) is IP monetization and M&A integration (Atomic Monster+Blumhouse).

Trade implications: Tactical: establish a 2–3% long in UVV sized to portfolio risk with a 3–6 month horizon, target +12–18% upside, stop -8%. Relative: run a 1:1 pair trade long UVV vs short DIS for 1–3 months to capture expected relative re‑rating if sequels sustain theatrical strength (target 8–12% relative). Options: buy 3–6 month UVV 15–20% OTM call spread to cap premium; hedge with a 90‑day DIS 10–15% OTM put spread if you hold media exposure.

Contrarian angles: Consensus underestimates ancillary upside—first film did >$300M global; merchandising/seasonal re‑airs could add 15–30% to lifetime revenue, so UVV upside may be underpriced. Conversely, Wicked’s 75% third‑week decline warns that Disney (DIS) theatrical upside is highly front‑loaded and may be overvalued on opening strength; monitor studio 10‑Qs for backend accrual changes and international weekly grosses as catalysts to reassess positions.

Key Decisions for Investors

• Establish a 2–3% long position in UVV (Universal/Blumhouse exposure) with a 3–6 month horizon; target +12–18% upside and set a hard stop at -8% to limit drawdown given weekend‑driven volatility.
• Implement a 1:1 pair trade, long UVV vs short DIS notional for 1–3 months to capture relative theatrical re‑rating; take profits if relative outperformance exceeds 8–12% or if weekly international grosses decelerate >20% week‑over‑week.
• Buy a 3–6 month UVV call spread 15–20% OTM to leverage upside while capping premium; simultaneously buy a 90‑day DIS put spread 10–15% OTM as a hedge against front‑loaded declines in Disney theatrical revenue.
• Overweight Media & Entertainment by +1–2% at expense of non‑IP Consumer Discretionary exposure; rebalance if studio 10‑Q reveals backend accrual increases >10% or if aggregate holiday box office drops >25% vs consensus.